For the first time, Thompson shares his journey living with gastroesophageal reflux disease (GERD) and experience using VOQUEZNA, as part of the ...

Its portfolio of drugs focuses on medical areas with unmet needs and includes AmBisome, Atripla, Biktarvy, Cayston, Complera ... Innovative Medicine and MedTech. Its Innovative Medicine segment ...

Its medicine portfolio treats multiple sclerosis ... Atripla, Biktarvy, Cayston, Complera, and others. Gilead Sciences, Inc. (NASDAQ:GILD) operates in over 35 countries. The company reported ...

The company offers Biktarvy, Genvoya, Descovy, Odefsey, Complera/Eviplera ... and comments:" Although final-quarter sales of ...

A Media Snippet accompanying this announcement is available by clicking on this link. FLORHAM PARK, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a ...

Apr. 4, 2025 — Researchers from chemistry, biology, and medicine are increasingly turning to AI models to develop new hypotheses. However, it is often unclear on which basis the algorithms come ...

The UAB Department of Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive training ...

Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...